Author(s):
Manjusha S. Kareppa, Priti B. Savant, Monika S. Jangid, Prajakta N. Acharya
Email(s):
kareppamanjusha2828@gmail.com
DOI:
10.52711/2231-5713.2023.00010 
Address:
Manjusha S. Kareppa, Priti B. Savant, Monika S. Jangid, Prajakta N. Acharya
1Assistant Professor, Department of Pharmaceutical Chemistry, Shri Balaji Shikshan Parsarak Mandal College of Pharmacy, Ambajogai - 431517, Maharashtra India.
2Department of Pharmaceutical, Chemistry SKVPM's Sahyadri College of Pharmacy, Methwade, Dist. Solapur 413307, Maharashtra India.
3Shri Balaji Shikshan Parsarak Mandal College of Pharmacy, Ambajogai - 431517, Maharashtra India.
4Department of Pharmaceutics, Shri Balaji Shikshan Parsarak Mandal College of Pharmacy, Ambajogai - 431517, Maharashtra India.
*Corresponding Author
Published In:
Volume - 13,
Issue - 1,
Year - 2023
ABSTRACT:
General practitioners are often the first doctors to see patients with Trigeminal neuralgia (TN). The aim of this article is to provide an up-to-date review of the literature regarding the presentation, classification, diagnosis and treatment of TN. The most painful neurological disease and is often described as "lightning" stuck to the face or a stinging sensation on the face. This condition is almost always unilateral and may involve one or more divisions of the trigeminal nerve. Trigeminal neuralgia, often called tic douloureux. MR imaging, including high-resolution trigeminal sequences, should be performed as part of the diagnostic workup. The most important aspects of TN management are discussed in this review article.
Cite this article:
Manjusha S. Kareppa, Priti B. Savant, Monika S. Jangid, Prajakta N. Acharya. A Comprehensive Review of Trigeminal neuralgia. Asian Journal of Pharmacy and Technology. 2023; 13(1):51-4. doi: 10.52711/2231-5713.2023.00010
Cite(Electronic):
Manjusha S. Kareppa, Priti B. Savant, Monika S. Jangid, Prajakta N. Acharya. A Comprehensive Review of Trigeminal neuralgia. Asian Journal of Pharmacy and Technology. 2023; 13(1):51-4. doi: 10.52711/2231-5713.2023.00010 Available on: https://ajptonline.com/AbstractView.aspx?PID=2023-13-1-10
REFERENCES:
1. Trigeminal Neuralgia (fothergill’s disease) in the 17th and 18th centuries . pearce JMS. JNeurolNeurosurg Psychiatry. 2003; 74: 1688. [PMC free article ][Pubmed][Google scholar].
2. Muhammad H Majeed, Sadaf Arooj, Muhammad Abbas Khokhar, Tamoor Mirza, Ali A aliand Zahid H Bajwa, 2018 Dec. 18.
3. Headache classification Committee of the international Headache Society(IHS). The international classification of headache disorder, 3rd edition. Cephalgia; an international journal of headache. 2018 Jan; [pubmed PMID: 29368949].
4. https://www.starpearls.com/articleLibrary/viewarticle/30604
5. https://www.ncbi.nlm.nih.gov/pmc/articles/pmc6384039
6. DR. Manjit Matharuand facial pain group, UCL queens quare institute of neurology, London WC1N3BG, UK; Manjit.matharu@nhs.net.
7. http://www.nhs.uk/ipgmedia/national/migraine%20action/assets/migraine and the trigeminal nerve.pdf
8. Cruccu G, Di Stefano G, truini A. trigeminal Neuralgia N Engl J Med .2020; 383: 754-62.
9. Muller D, Obermann M, Yoon M-S, etal. Prevalence of trigeminal neuralgia and persistent idiopathic facial pain: apopulation-based study. Cephalgia 2011; 31: 1542-8.
10. Blasberg B, Greenberg MS. Orofacial pai. In Greenberg MS, Gick M, editors. Burkets oral medicine diagnosis and treatment, 10th edoition. Hamilton; Ontario BC Decker inc;2003.
11. Jannetia PJ. Arterial compression of the trigeminalnerve at the pons in patients with trigeminal neuralgia. J. Neurosurg.1967; 26(1): 159-62.
12. Kraff RM. Trigeminal neuralgia. Amfam physician, 2008; 77(9): 1291-6.
13. Headache classification sub committee of the international headache society. The international classification of headache disorders 3rd edition. Cephalgia, 2018; 38: 1-211.
14. The international classification of headache disorders, 3rd edition (beta version) headache classification committee of the international headache society (IHS) https://journal.sagepub.com/ doi/10.1177/0333102413485658.cephalgia.2013;33:629-808[pubmed][Googlescholar].
15. AAA-EFNS guidelines on trigeminal neuralgia management. Cruccu G, gronseth G, Alksne J, etal. EurJ Neurol. 2008; 15: 1013-1028. [pubmed][googlescholar]
16. O’C Callaghan L, Floden L, vinikoor-Imler L, etal. Burden of illness of trigeminal neuralgia among patients managedina specialist canter in England J headache pain. 2020; 21: 130.
17. Zakrzewska JM, Chaudhary Z, Nurmikko TJ, etal. Lamotrigine [Lamictal] in refractory TN; results from a double blind placebo controlled crossover trial. Pain. 1997; 73: 223-30
18. Kugelberg E, Lindblom U. the mechanism of thrpainin TNJ. Neurol Neurosurg psychiatry. 1959; 22: 36-43.